Prodrug approach: An overview of recent cases.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European journal of medicinal chemistry

• Publication date

  2017-02-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2016.10.061PMID 27823878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel prodrugs with a spontaneous cleavable guanidine moiety.

  2016cited by this paper
• Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent.

  2016cited by this paper
• Discovery of an Orally Active and Liver-Targeted Prodrug of 5-Fluoro-2'-Deoxyuridine for the Treatment of Hepatocellular Carcinoma.

  2016cited by this paper
• Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy.

  2016cited by this paper
• New formulation of old aspirin for better delivery.

  2016cited by this paper
• Rational design of multifunctional small-molecule prodrugs for simultaneous suppression of cancer cell growth and metastasis in vitro and in vivo.

  2016cited by this paper
• In situ activation of a doxorubicin prodrug using imaging-capable nanoparticles.

  2016cited by this paper
• Design and synthesis of peptide conjugates of phosphoramide mustard as prodrugs activated by prostate-specific antigen.

  2016cited by this paper
• Melanoma-targeted delivery system (part 1): design, synthesis and evaluation of releasable disulfide drug by glutathione.

  2015cited by this paper
• Diastereoselective synthesis of P-chirogenic phosphoramidate prodrugs of nucleoside analogues (ProTides) via copper catalysed reaction.

  2015cited by this paper
• Antimalarial activity of prodrugs of N-branched acyclic nucleoside phosphonate inhibitors of 6-oxopurine phosphoribosyltransferases.

  2015cited by this paper
• Metabolic methanol: molecular pathways and physiological roles.

  2015cited by this paper
• Degradation of Curcumin: From Mechanism to Biological Implications.

  2015cited by this paper
• Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay.

  2015cited by this paper
• Water-soluble prodrugs of paclitaxel containing self-immolative disulfide linkers.

  2015cited by this paper
• Optimization of a Stable Linker Involved DEVD Peptide-Doxorubicin Conjugate That Is Activated upon Radiation-Induced Caspase-3-Mediated Apoptosis.

  2015cited by this paper
• Induced phenotype targeted therapy: radiation-induced apoptosis-targeted chemotherapy.

  2015cited by this paper
• Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.

  2015cited by this paper
• β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: an update.

  2014cited by this paper
• Complex adaptive therapeutic strategy (CATS) for cancer.

  2014cited by this paper
• Aromatic nitrogen mustard-based prodrugs: activity, selectivity, and the mechanism of DNA cross-linking.

  2014cited by this paper
• Efficiency of Incorporation and Chain Termination Determines the Inhibition Potency of 2′-Modified Nucleotide Analogs against Hepatitis C Virus Polymerase

  2014cited by this paper
• Nanostructured drug delivery for better management of tuberculosis.

  2014cited by this paper
• Modern Prodrug Design for Targeted Oral Drug Delivery

  2014cited by this paper
• Toward Hypoxia-Selective DNA-Alkylating Agents Built by Grafting Nitrogen Mustards onto the Bioreductively Activated, Hypoxia-Selective DNA-Oxidizing Agent 3-Amino-1,2,4-benzotriazine 1,4-Dioxide (Tirapazamine)

  2014cited by this paper
• Targeting SH2 domains in breast cancer.

  2014cited by this paper
• Propyphenazone-based analogues as prodrugs and selective cyclooxygenase-2 inhibitors.

  2014cited by this paper
• Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives.

  2014cited by this paper
• Synthesis and cancer stem cell-based activity of substituted 5-morpholino-7H-thieno[3,2-b]pyran-7-ones designed as next generation PI3K inhibitors.

  2013cited by this paper
• Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles.

  2012cited by this paper
• Tuning the activity of platinum(IV) anticancer complexes through asymmetric acylation.

  2012cited by this paper
• Synthesis and antiviral activities of hexadecyloxypropyl prodrugs of acyclic nucleoside phosphonates containing guanine or hypoxanthine and a (S)-HPMP or PEE acyclic moiety

  2012cited by this paper
• Synthesis, chemical and enzymatic hydrolysis, and aqueous solubility of amino acid ester prodrugs of 3-carboranyl thymidine analogs for boron neutron capture therapy of brain tumors.

  2012cited by this paper
• Toward eradicating HIV reservoirs in the brain: inhibiting P-glycoprotein at the blood-brain barrier with prodrug abacavir dimers.

  2012cited by this paper
• Synthesis and characterization of a novel prostate cancer-targeted phosphatidylinositol-3-kinase inhibitor prodrug.

  2012cited by this paper
• Synthesis and evaluation of mutual prodrugs of ibuprofen with menthol, thymol and eugenol.

  2012cited by this paper
• Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 2. Synthesis and characterization of a novel imide-type prodrug for improving oral absorption.

  2012cited by this paper
• Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment 6. Preclinical and human pharmacokinetic profiling of BMS-663749, a phosphonooxymethyl prodrug of the HIV-1 attachment inhibitor 2-(4-benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043)

  2012cited by this paper
• Novel phosphoramidate prodrugs of N-acetyl-(D)-glucosamine with antidegenerative activity on bovine and human cartilage explants.

  2012cited by this paper
• Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach.

  2011cited by this paper
• Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3.

  2011cited by this paper
• Synthesis, Characterization and Biological Evaluation of Succinate Prodrugs of Curcuminoids for Colon Cancer Treatment

  2011cited by this paper
• Discovery of phosphoric acid mono-{2-[(E/Z)-4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-benzoylimino]-thiazol-3-ylmethyl} ester (Lu AA47070): a phosphonooxymethylene prodrug of a potent and selective hA(2A) receptor antagonist.

  2011cited by this paper
• Structure-Based Discovery of A2A Adenosine Receptor Ligands

  2010cited by this paper
• Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.

  2010cited by this paper
• Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977

  2010cited by this paper
• Bioprecursor prodrugs: molecular modification of the active principle.

  2010cited by this paper
• Synthesis, cytotoxic and combined cDDP activity of new stable curcumin derivatives.

  2009cited by this paper
• Prodrugs: bridging pharmacodynamic/pharmacokinetic gaps.

  2009cited by this paper
• Protein nanoparticles as drug carriers in clinical medicine.

  2008cited by this paper
• In Vitro and In Vivo Evaluation of Microparticulate Drug Delivery Systems Composed of Macromolecular Prodrugs

  2008cited by this paper
• The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist

  2008cited by this paper
• Designing Prodrugs and Bioprecursors

  2008cited by this paper
• Your prodrug releases formaldehyde: should you be concerned? No!

  2008cited by this paper
• Prodrugs: design and clinical applications

  2008cited by this paper
• Synthesis, radiosynthesis, and biological evaluation of new proteasome inhibitors in a tumor targeting approach.

  2008cited by this paper
• Carboranyl thymidine analogues for neutron capture therapy.

  2007cited by this paper
• Synthesis and in vivo evaluation of non-hepatotoxic acetaminophen analogs.

  2007cited by this paper
• Paclitaxel prodrugs: toward smarter delivery of anticancer agents.

  2006cited by this paper
• Potential Tuberculostatic Agent: Micelle‐forming Pyrazinamide Prodrug

  2006cited by this paper
• Enzymes involved in the bioconversion of ester-based prodrugs.

  2006cited by this paper
• Review article: high‐dose aminosalicylates to induce and maintain remissions in ulcerative colitis

  2006cited by this paper
• The Impact of ΔG on the Oral Bioavailability of Low Bioavailable Therapeutic Agents

  2005cited by this paper
• Design, development and synthesis of mixed bioconjugates of piperic acid-glycine, curcumin-glycine/alanine and curcumin-glycine-piperic acid and their antibacterial and antifungal properties.

  2005cited by this paper
• Oseltamivir in the management of influenza

  2005cited by this paper
• Prodrugs and Drug Delivery Systems

  2004cited by this paper
• Synthesis and antileishmanial activity of novel buparvaquone oxime derivatives.

  2004cited by this paper
• Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.

  2004cited by this paper
• New antiviral nucleoside prodrugs await application.

  2003cited by this paper
• A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: design and synthesis of isotaxel.

  2003cited by this paper
• Chromosome stability, DNA recombination and the BRCA2 tumour suppressor.

  2001cited by this paper
• Targeted prodrug design to optimize drug delivery

  2000cited by this paper
• Intestinal permeation enhancers.

  2000cited by this paper
• Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.

  2000cited by this paper
• Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite.

  1996cited by this paper
• Catalytic mechanism of enzymic glycosyl transfer

  1990cited by this paper
• Nomega-linked arginine peptides.

  1976cited by this paper
• N ω -linked arginine peptides

  1976cited by this paper
• Chemical Aspects of Selective Toxicity

  1958cited by this paper
• Selective Toxicity

  1950cited by this paper

• Spatiotemporal control of prodrug activation through external stimuli for effective and safe on-site release in solid tumors: From current advances to future perspectives.

  2026cites this paper
• Photoredox Unmasking of Aromatic C-H Bonds in Living Environments Enabled by Thianthrenium Salts.

  2026cites this paper
• Novel Prodrug-Inspired Eugenol Derivatives with Enhanced Bioavailability, Anti-Diabetic and Anti-Glycation Efficacies

  2025cites this paper
• Prodrug strategy: molecular design for improving oral drug absorption.

  2025cites this paper
• Structure-enabled discovery of carboxylate esters prodrugs as potential potent inhibitors targeting Glutaminase C.

  2025cites this paper
• Pd-Catalyzed Asymmetric Allylic Alkylation of Carboxylic Acids for the Synthesis of Chiral Butenolidyl Ester Prodrugs and Peptide-Drug Conjugates.

  2025cites this paper
• Nucleophile-triggered prodrug release from polymer hydrogels

  2025cites this paper
• Synthesis and Enzyme Hydrolysis Study of Acyloxyalkyl Carbamates as New Prodrugs for Amines

  2025cites this paper
• Molecular docking, molecular dynamics simulation, and ADME profiling of novel benzoxazolone-based OGT inhibitors

  2025cites this paper
• Design of cathepsin-sensitive linkers for tumor-selective bioconjugate drug delivery.

  2025cites this paper
• Prodrugs in Modern Medicine: Strategies, Applications, and Future Directions

  2025cites this paper
• Advanced Drug Delivery Strategies to Overcome Solubility and Permeability Challenges: Driving Biopharmaceutical Advancements Toward Commercial Success

  2025cites this paper
• Phytochemicals of Punica granatum and their therapeutic potential: A computational approach targeting WNT signaling in colorectal cancer

  2025cites this paper
• Tumor-specific biochemical nanoconversion of self-assembled peptide-conjugated paclitaxel-docetaxel-based nanoparticles

  2025cites this paper
• Chromone-Based Copper(II) Complexes as Potential Antitumour Agents: Synthesis, Chemical Characterisation and In Vitro Biological Evaluation

  2025cites this paper
• Advancements in Targeted Therapies for Colorectal Cancer: Innovative Drug Formulation and Delivery Strategies

  2025cites this paper
• Recent Advances in Di-, Tri-Substituted Mono-Thiazoles, and Bis-Thiazoles: Factors Affecting Biological Activities, Future Aspects, and Challenges.

  2025cites this paper
• Synthesis of O‐Nicotinoyl‐Substituted Depot Forms of Biologically Active N6‐Benzyladenosine Analogs

  2025cites this paper
• Light-mediated Activation/Deactivation Control and in vitro ADMETox Profiling of a Donepezil-like Dual AChE/MAO-B Inhibitor.

  2025cites this paper
• Development of a bispecific antibody–drug conjugate targeting EpCAM and CLDN3 for the treatment of multiple solid tumors

  2025cites this paper
• Probing into the plasma stability and microsomal stability of thiol-based prodrug derivatives: Using IYS-15, an HDAC inhibitor as the model thiol.

  2025cites this paper
• In silico prediction of metabolic stability for ester-containing molecules: Machine learning and quantum mechanical methods

  2025cites this paper
• Optimization and characterization of xanthan gum based multiparticulate formulation for colon targeting

  2024cites this paper
• Activation of Dithiolopyrrolone Antibiotics by Cellular Reductants.

  2024cites this paper
• Prodrugging fungicidal amphotericin B significantly decreases its toxic effects.

  2024cites this paper
• Azo-linked 5-ASA-coumarin prodrug: Fluorescent tracking for colonic drug release in UC treatment.

  2024cites this paper
• The Antiviral and Antimalarial Prodrug Artemisinin from the Artemisia Species: A Review

  2024cites this paper
• Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs.

  2024cites this paper
• Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer.

  2024cites this paper
• Carrier-free nano-prodrugs for minimally invasive cancer therapy.

  2024cites this paper
• PEGylation renders carnosine resistant to hydrolysis by serum carnosinase and increases renal carnosine levels

  2024cites this paper
• Lipid-conjugated nucleoside monophosphate and monophosphonate prodrugs: A versatile drug delivery paradigm.

  2024cites this paper
• Ocular drug-metabolizing enzymes: focus on esterases

  2024cites this paper
• Enantioselective Synthesis of Tetra-substituted 3-Hydroxyphthalide Esters by Isothiourea-Catalysed Acylative Dynamic Kinetic Resolution.

  2024cites this paper
• Synthesis and biological evaluation of the novel chrysin prodrug for non-alcoholic fatty liver disease treatment

  2024cites this paper
• Natural Amino Acid-Bearing Carbamate Prodrugs of Daidzein Increase Water Solubility and Improve Phase II Metabolic Stability for Enhanced Oral Bioavailability.

  2024cites this paper
• NQO1-activated multifunctional theranostic probe for imaging-guided mitochondria-targeted photodynamic therapy and boosting immunogenic cell death.

  2024cites this paper
• Ibuprofen with Amino Acid Dipeptide Conjugation: A Novel Prodrug for the Management of Alzheimer’s Disease Complications

  2024cites this paper
• Exploring the next generation of antibody–drug conjugates

  2024cites this paper
• Phosphate Prodrugs: An Approach to Improve the Bioavailability of Clinically Approved Drugs.

  2023cites this paper
• Prodrug Approach: NSAID Conjugates of Platinum Compounds as Anti-Cancer Agents

  2023cites this paper
• Novel ibuprofen prodrug: A possible promising agent for the management of complications of Alzheimer’s disease

  2023cites this paper
• The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors

  2023cites this paper
• Evaluating physiochemical properties of FDA-approved orally administered drugs

  2023cites this paper
• Novel drug delivery strategies for antidepressant active ingredients from natural medicinal plants: the state of the art

  2023cites this paper
• Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy.

  2023cites this paper
• Nucleoside Scaffolds and Carborane Clusters for Boron Neutron Capture Therapy: Developments and Future Perspective.

  2023cites this paper
• Catalytic olefin metathesis in blood

  2023cites this paper
• Alzheimer’s Disease and Green Tea: Epigallocatechin-3-Gallate as a Modulator of Inflammation and Oxidative Stress

  2023cites this paper
• A Review of 20 Years Research Progression on Prodrug Technology in Inhaled Medications

  2023cites this paper
• Biotransformation and metabolism of three methyl salicylate glycosides by gut microbiota in vitro.

  2023cites this paper
• Novel formulation approaches for synergistic codelivery based on lipid nanocarriers.

  2023cites this paper
• A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects

  2023cites this paper
• Lutein-stachyose (LS) amphiphilic oligosaccharide derivatives improve the oral bioavailability of lutein.

  2023cites this paper
• A Self-Immolative Linker for the pH-Responsive Release of Amides

  2023cites this paper
• Design, synthesis and evaluation of a series of potential prodrugs of a Bruton’s tyrosine kinase (BTK) inhibitor

  2023cites this paper
• The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy.

  2023cites this paper
• An Overview of Taste-Masking Technologies: Approaches, Application, and Assessment Methods

  2023cites this paper
• "Breaking bud": the effect of direct chemical modifications of phytocannabinoids on their bioavailability, physiological effects, and therapeutic potential.

  2023cites this paper
• Carrier-free nanomedicines for cancer treatment

  2022cites this paper
• From solo to duet, intersections of natural product assembly with self-resistance.

  2022cites this paper
• Conjugates of 3-phenyllactic acid and tryptophan enhance root-promoting activity without adverse effects in Vigna angularis.

  2022cites this paper
• Methionine Sulfoxide Reductase A in Human and Mouse Tissues is Responsible for Sulindac Activation, Making a Larger Contribution than the Gut Microbiota

  2022cites this paper
• Epigallocatechin gallate: Phytochemistry, bioavailability, utilization challenges, and strategies.

  2022cites this paper
• Synthesis, physicochemical properties, and protective effects of a novel water-soluble tetrahydrocurcumin-diglutaric acid prodrug on ethanol-induced toxicity in HepG2 cells

  2022cites this paper
• Chitosan-based oral colon-specific delivery systems for polyphenols: recent advances and emerging trends.

  2022cites this paper
• Thermal release of quinoliniums and simple alkenes from their photocycloadducts by a retro-Diels–Alder reaction

  2022cites this paper
• Strategies and Progresses for Enhancing Targeted Antibiotic Delivery.

  2022cites this paper
• Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy.

  2022cites this paper
• Chinese medicinal herbs as potential prodrugs for obesity

  2022cites this paper
• A NOVEL FORMULATION DESIGN FOR EXTENDED RELEASE TABLET OF ETODOLAC FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

  2022cites this paper
• A colon-targeted podophyllotoxin nanoprodrug: synthesis, characterization, and supramolecular hydrogel formation for the drug combination.

  2021cites this paper
• Protective Effects of a Lutein Ester Prodrug, Lutein Diglutaric Acid, against H2O2-Induced Oxidative Stress in Human Retinal Pigment Epithelial Cells

  2021cites this paper
• Semisynthetic Derivatives of the Verticillin Class of Natural Products through Acylation of the C11 Hydroxy Group.

  2021cites this paper
• In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase

  2021cites this paper
• Prodrugs

  2021cites this paper
• Prodrugs - Current development and applications in ocular drug delivery

  2021cites this paper
• Pharmaceutical Applications of Vitamin E TPGS

  2021cites this paper
• Phosphate-Based Self-Immolative Linkers for the Delivery of Amine-Containing Drugs

  2021cites this paper
• Development, Characterization and Pharmacological Investigation of Umbelliferone Conjugates of NSAIDs

  2021cites this paper
• Small-Molecule Prodrug Nanoassemblies: An Emerging Nanoplatform for Anticancer Drug Delivery.

  2021cites this paper
• Design, Synthesis, Characterization of New Carbamates of 4-Nitrophenylchloroformate and Their Antimicrobial and Antioxidant Activities: an In Vitro and In Silico Approach

  2021cites this paper
• Prodrug activation by gold artificial metalloenzyme-catalyzed synthesis of phenanthridinium derivatives via hydroamination.

  2021cites this paper
• Synthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-1-ols—Intracellular TBBi-Based CK2 Inhibitors with Proapoptotic Properties

  2021cites this paper
• The length of disulfide bond-containing linkages impacts the oral absorption and antitumor activity of paclitaxel prodrug-loaded nanoemulsions.

  2021cites this paper
• Biomedical Applications of Nano‐Engineered Enzymes: Current Status and Future Direction

  2021cites this paper
• Integration of a Diselenide Unit Generates Fluorogenic Camptothecin Prodrugs with Improved Cytotoxicity to Cancer Cells.

  2021cites this paper
• The role of DMPK science in improving pharmaceutical research and development efficiency.

  2021cites this paper
• Design Principles and Development of Prodrugs for Multiply Active Antibacterials

  2021cites this paper
• Disulfide based prodrugs for cancer therapy

  2020cites this paper
• Prodrug Design to Enhance Bioavailability and Systemic Delivery

  2020cites this paper
• How to improve the selectivity of drugs

  2020cites this paper
• Use of prodrugs in cancer therapy - A Review

  2020influential citation
• The simultaneous determination of naringenin and its valine carbamate prodrug in rat plasma using supercritical fluid chromatography -tandem mass spectrometric method.

  2020cites this paper
• Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lipophilic Derivate of Gemcitabine

  2020cites this paper
• Prodrug design for improving the biopharmaceutical properties of therapeutic drugs

  2020cites this paper
• Chiral Bicyclic Imidazole-Catalyzed Acylative Dynamic Kinetic Resolution for the Synthesis of Chiral Phthalidyl Esters.

  2020cites this paper
• Recent advances in colon drug delivery systems.

  2020cites this paper
• Fragment-based approach to novel bioactive purine derivatives

  2020cites this paper
• Nasal Absorption Enhancement of Protein Drugs Independent to Their Chemical Properties in the Presence of Hyaluronic Acid Modified with Tetraglycine-L-octaarginine.

  2020cites this paper